Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Buttyan

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
The Prostate|December 14, 2002
Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cellsMohamed A Ghafar, Aristotelis G Anastasiadis, Min-Wei Chen, et al.
Cell Cycle (Georgetown, Tex.)|November 10, 2011
Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disordersAnna B Glinskii, Shuang Ma, Jun Ma, et al.
Urology|May 16, 2006
Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumorsScott M Gilbert, Jared M Whitson, Mahesh Mansukhani, et al.
European Urology|August 26, 2019
The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease managementVarune Rohan Ramnarine, Maxim Kobelev, Ewan A Gibb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cellsAlexandre de la Taille, Mark A Rubin, Min-Wei Chen, et al.
Cancer Research|June 17, 2005
A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cellsXuezhen Yang, Min-Wei Chen, Stephane Terry, et al.
Journal of Cancer Research and Clinical Oncology|July 24, 2002
Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha)Aristotelis G Anastasiadis, Mohamed A Ghafar, Laurent Salomon, et al.
Oncogene|November 7, 2002
The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cellsMin-Wei Chen, Francis Vacherot, Alexandre De La Taille, et al.
Molecular Cancer|April 28, 2010
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cellsMengqian Chen, Michael A Feuerstein, Elina Levina, et al.
The Prostate|April 26, 2006
Protocadherin-PC promotes androgen-independent prostate cancer cell growthStephane Terry, Luis Queires, Sixtina Gil-Diez-de-Medina, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
The Prostate|December 14, 2002
Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cellsMohamed A Ghafar, Aristotelis G Anastasiadis, Min-Wei Chen, et al.
Cell Cycle (Georgetown, Tex.)|November 10, 2011
Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disordersAnna B Glinskii, Shuang Ma, Jun Ma, et al.
Urology|May 16, 2006
Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumorsScott M Gilbert, Jared M Whitson, Mahesh Mansukhani, et al.
European Urology|August 26, 2019
The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease managementVarune Rohan Ramnarine, Maxim Kobelev, Ewan A Gibb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cellsAlexandre de la Taille, Mark A Rubin, Min-Wei Chen, et al.
Cancer Research|June 17, 2005
A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cellsXuezhen Yang, Min-Wei Chen, Stephane Terry, et al.
Journal of Cancer Research and Clinical Oncology|July 24, 2002
Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha)Aristotelis G Anastasiadis, Mohamed A Ghafar, Laurent Salomon, et al.
Oncogene|November 7, 2002
The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cellsMin-Wei Chen, Francis Vacherot, Alexandre De La Taille, et al.
Molecular Cancer|April 28, 2010
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cellsMengqian Chen, Michael A Feuerstein, Elina Levina, et al.
The Prostate|April 26, 2006
Protocadherin-PC promotes androgen-independent prostate cancer cell growthStephane Terry, Luis Queires, Sixtina Gil-Diez-de-Medina, et al.
Pageof 7